Vancouver, British Columbia–(Newsfile Corp. – March 11, 2026) – Eureka Lithium Corp. (CSE: ERKA) (OTCQB: UREKF) (FSE: S580) (“Eureka Lithium” or “Eureka” or the “Company“) is pleased to announce that it intends to complete a non-brokered private placement financing under the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions (the “LIFE Exemption“) of up to 4,761,904 units of the Company (the “Units“) at a price of $0.42 per Warrant for aggregate gross proceeds of up to $2,000,000 (the “LIFE Offering“). Each Unit will be comprised of one common share (the “Common Shares“) and one Common Share purchase warrant (the “Warrants“).

Each Warrant will entitle the holder to purchase one Common Share (the “Warrant Shares“) at an exercise price of $0.45 per Warrant Share for a period of 24 months from the closing date of the LIFE Offering. The Warrants will be governed by the terms and conditions set forth in the certificates representing the Warrants.

The Company also intends to complete two concurrent non-brokered private placements (the “Concurrent Offerings“). First, an offering of up to 4,761,904 units (the “Concurrent Private Placement Units“) at a price of $0.42 per Concurrent Private Placement Unit for aggregate gross proceeds of up to $2,000,000. Each Concurrent Private Placement Unit will be comprised of one Common Share and one Common Share purchase warrant (the “Concurrent Private Placement Warrants“), and with each Concurrent Private Placement Warrant being exercisable for a period of 24 months, to acquire one Common Share (the “Concurrent Private Placement Warrant Shares“) at an exercise price of $0.45 per Concurrent Private Placement Warrant Share.

Second, an offering of up to 4,166,666 units (the “FT Units“) at a price of $0.48 per FT Unit for aggregate gross proceeds of up to $2,000,000. Each FT Unit being comprised of one Common Share issued on a “flow-through” bass and one (non-flow-through) Common Share purchase warrant (the “FT Warrants“), with each FT Warrant being exercisable to acquire, for a period of 24 months, one (non-flow-through) Common Share (the “FT Warrant Share“) at an exercise price of $0.60 per FT Warrant Share. The Concurrent Private Placement Warrants and FT Warrants will be governed by the terms and conditions set forth in the certificates representing the Warrants.

The securities issued in connection with the Concurrent Offerings will be subject to a statutory hold period of four months and one day from the date of issuance, in accordance with applicable Canadian securities laws.

The Company may pay finders’ fees in accordance with the policies of the Canadian Securities Exchange (“CSE”). Closing of the LIFE Offering and the Concurrent Offerings remain subject to regulatory approvals, including approval of the CSE.

The Company intends to use the net proceeds from the LIFE Offering and the Concurrent Offerings for exploration expenses on the Company’s properties in Quebec and British Columbia and for general and administrative expenditures.